These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32691907)

  • 1. Reply to a Letter by Dr. Stefani and Colleagues on: "Auditory Dysfunction in Parkinson's Disease".
    Jafari Z; Kolb BE; Mohajerani MH
    Mov Disord; 2020 Jul; 35(7):1284-1285. PubMed ID: 32691907
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the Letter to the Editor: Stefani A, "Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History".
    Bogers JS; Bloem BR; den Heijer JM
    J Parkinsons Dis; 2024; 14(2):359-360. PubMed ID: 38457154
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding the role of heteroreceptor complexes in the central nervous system.
    Fuxe K; Borroto-Escuela D; Fisone G; Agnati LF; Tanganelli S
    Curr Protein Pept Sci; 2014; 15(7):647. PubMed ID: 25256022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to Rumrich and colleagues (What does "Parkinson's disease mortality" mean?).
    Cole-Hunter T; Zhang J; Lim YH; Samoli E; Chen J; Strak M; Wolf K; Weinmayr G; Zitt E; Hoffmann B; Jöckel KH; Mortensen LH; Ketzel M; Méndez DY; Ljungman P; Nagel G; Pershagen G; Rizzuto D; Schramm S; Brunekreef B; Hoek G; Andersen ZJ
    Environ Int; 2023 Mar; 173():107853. PubMed ID: 36931779
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to letter: Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta-analysis.
    Alves M; Caldeira D; Ferro JM; Ferreira JJ
    Eur J Neurol; 2020 Feb; 27(2):e12. PubMed ID: 31710751
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to letter to the editor "Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges".
    Velisar A; Bronte-Stewart H
    Brain Stimul; 2019; 12(5):1330-1331. PubMed ID: 31235368
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to letter: Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials.
    Rodrigues TM; Castro Caldas A; Ferreira JJ
    Parkinsonism Relat Disord; 2016 Aug; 29():123-4. PubMed ID: 27237107
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to the Letter "What does characterize exercise guidelines for Parkinson's disease?".
    Martignon C; Pedrinolla A; Ruzzante F; Giuriato G; Laginestra FG; Bouça-Machado R; Ferreira JJ; Tinazzi M; Schena F; Venturelli M
    Aging Clin Exp Res; 2021 Mar; 33(3):677-678. PubMed ID: 33389712
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory Bowel Disease and Parkinson's Disease: A Reply to Letter to the Editor of Shih-Wei Lai.
    Weimers P; Halfvarson J; Saunders-Pullman R; Ludvigsson JF; Peter I; Olén O; Burisch J
    Inflamm Bowel Dis; 2019 Sep; 25(10):e127. PubMed ID: 31406980
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to letter to the editor "tDCS effect on cognitive performance in Parkinson's disease" by Biundo et al.
    Cotelli M; Manenti R; Brambilla M; Borroni B
    Mov Disord; 2016 Aug; 31(8):1253-5. PubMed ID: 27270985
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to letter: Transcranial magnetic stimulation for Parkinson's disease.
    Kojovic M; Bologna M; Edwards MJ; Rothwell JC; Bhatia KP
    Mov Disord; 2015 Dec; 30(14):1973-4. PubMed ID: 26573695
    [No Abstract]   [Full Text] [Related]  

  • 12. In reply to the letter to the editor regarding "Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study".
    Zenesini C; Baldin E; Vignatelli L; D'Alessandro R
    J Neurol Sci; 2020 Jan; 408():116511. PubMed ID: 31732173
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective delayed response deficits in Parkinson's and Alzheimer's disease.
    Freedman M; Oscar-Berman M
    Arch Neurol; 1986 Sep; 43(9):886-90. PubMed ID: 3741206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In reply to the letter to the editor regarding "TGM6 variants in Parkinson's disease: clinical findings and functional evidence".
    Chen K; Tan Y; Zhao YX
    J Integr Neurosci; 2020 Dec; 19(4):739-740. PubMed ID: 33378850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to letter: Plasma fasting cholesterol profiles and age at onset in Parkinson's disease.
    Swanson CR; Alcalay RN; Chen-Plotkin A
    Mov Disord; 2015 Dec; 30(14):1975-6. PubMed ID: 26584479
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to: Kidney Dysfunction and Risk of Parkinson's Disease: The Issue of Equations and Large Number".
    Nam GE; Kim NH; Han K; Choi KM; Chung HS; Kim JW; Han B; Cho SJ; Jung SJ; Yu JH; Park YG; Kim SM
    Mov Disord; 2020 Mar; 35(3):520. PubMed ID: 32166801
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel.
    Fernandez HH; Standaert DG; Chatamra K; Benesh JA
    Mov Disord; 2015 Sep; 30(10):1435-6. PubMed ID: 26179940
    [No Abstract]   [Full Text] [Related]  

  • 18. "Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis": Answer to Wang and colleagues.
    Wolters AF; van de Weijer SCF; Leentjens AFG; Duits AA; Jacobs HIL; Kuijf ML
    Parkinsonism Relat Disord; 2019 Sep; 66():253-254. PubMed ID: 31431324
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to letter: Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel.
    Marano M; Salomone G; di Biase L; Di Lazzaro V; Melgari JM
    Parkinsonism Relat Disord; 2016 Apr; 25():114-5. PubMed ID: 26698016
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply Letter - Polypharmacy is a determinant of hospitalization in Parkinson's disease.
    Giovannini S; Laudisio A; Navarini L; Loreti C; Biscotti L; Padua L; Bernabei R; Zuccalà G
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7193-7194. PubMed ID: 34919216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.